| Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients (NCT06513949) | Implicit Bioscience | 2026-06-17 |
| VExUS in Ards Patients and Association with AKI (NCT06805409) | Assistance Publique - Hôpitaux de Paris | 2024-12-02 |
| Evaluation of VQm PHM on Pulmonary Health Parameters for ICU (NCT06147674) | Rostrum Medical Innovations Inc. | 2024-01-15 |
| ALI/ARDS Clinical Sub-phenotyping Study (NCT06123962) | China-Japan Friendship Hospital | 2023-12-14 |
| FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis (NCT05807802) | Tianjin First Central Hospital | 2023-05-01 |
| Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial (NCT05002478) | Medical University of Vienna | 2022-07-30 |
| Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium (NCT05343338) | First Affiliated Hospital Xi'an Jiaotong University | 2022-04-20 |
| Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS (NCT05153525) | Tanta University | 2022-01-06 |
| Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 (NCT05137795) | APR Applied Pharma Research s.a. | 2021-12-15 |
| Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress (NCT04935697) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2021-08-04 |
| Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS (NCT04482712) | The University of Texas Health Science Center at San Antonio | 2021-04-01 |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (NCT04360096) | APR Applied Pharma Research s.a. | 2021-02-15 |
| The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) (NCT04389671) | Windtree Therapeutics | 2021-01-05 |
| Mechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury (NCT04607434) | The First Hospital of Jilin University | 2021-01-01 |
| Rehabilitation for People With COVID-19 in ICU (NCT04381338) | University of Padova | 2020-02-28 |
| SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19 (NCT04355494) | Alexion Pharmaceuticals, Inc. | |